08 September 2003
Comparison of prescribed and delivered doses of dialysis using anthropometrically and bioelectrically measured patient volumes
Wojciech T. Załuska, Daniel Schneditz, Andrzej Swatowski, Andrzej Jaroszyński, Andrzej KsiążekMed Sci Monit 2003; 9(9): CR405-410 :: ID: 13193
Abstract
Background:One of the uncertainties in the prescription of dialysis dose, measured as Kt/V for urea (Kt/Vu), is the volume of urea distribution (V). The aim of our study was to compare two different approaches to estimating V and Kt/V, respectively, and to compare the predicted (prescribed) dose with the actually delivered dose, measured by urea kinetics.Material/Methods:V was estimated using anthropometric measures with the Watson formula (VWatson), and also by multi-frequency bioimpedance analysis (VBIS). Both volumes were determined for the state at the end of dialysis and ultrafiltration, and then used to predict (prescribe) Kt/VWatson and Kt/VBIS, respectively. The delivered Kt/Vu was determined from pre- and postdialysis urea concentrations.Results:209 patients were studied in 254 measurements. VWatson and VBIS correlated significantly (VBIS=0.64*VWatson+15.03, r2=0.67) but VWatson (36.0I6.4 L) was higher than VBIS (32.5I8.1 L). The bias between techniques was 3.5I4.6 L. As a consequence of volume underestimation, Kt/VBIS was overestimated (1.44I0.38) when compared to the actually delivered Kt/Vu (1.28I0.32). However, Kt/VWatson (1.27I0.25) based on VWatson was almost identical to the actually delivered treatment dose.Conclusions:The close correspondence between the delivered and predicted (prescribed) dose of dialysis using anthropometric volumes leads to the conclusion that in this study kinetic distribution volume was best described by VWatson. The overestimation of prescribed dialysis dose based on bioimpedance analysis suggests caution in the use of bioimpedance volumes, because of the risk of prescribing inadequate dialysis.
Keywords: Renal Dialysis - methods
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952